1. Home
  2. ANGI vs RAPP Comparison

ANGI vs RAPP Comparison

Compare ANGI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • RAPP
  • Stock Information
  • Founded
  • ANGI 1995
  • RAPP 2022
  • Country
  • ANGI United States
  • RAPP United States
  • Employees
  • ANGI N/A
  • RAPP N/A
  • Industry
  • ANGI Advertising
  • RAPP
  • Sector
  • ANGI Consumer Discretionary
  • RAPP
  • Exchange
  • ANGI Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • ANGI 574.1M
  • RAPP 463.8M
  • IPO Year
  • ANGI 2017
  • RAPP 2024
  • Fundamental
  • Price
  • ANGI $11.60
  • RAPP $10.15
  • Analyst Decision
  • ANGI Buy
  • RAPP Strong Buy
  • Analyst Count
  • ANGI 8
  • RAPP 5
  • Target Price
  • ANGI $28.86
  • RAPP $35.00
  • AVG Volume (30 Days)
  • ANGI 1.6M
  • RAPP 259.3K
  • Earning Date
  • ANGI 05-06-2025
  • RAPP 05-10-2025
  • Dividend Yield
  • ANGI N/A
  • RAPP N/A
  • EPS Growth
  • ANGI N/A
  • RAPP N/A
  • EPS
  • ANGI 0.70
  • RAPP N/A
  • Revenue
  • ANGI $1,185,112,000.00
  • RAPP N/A
  • Revenue This Year
  • ANGI N/A
  • RAPP N/A
  • Revenue Next Year
  • ANGI $4.67
  • RAPP N/A
  • P/E Ratio
  • ANGI $16.57
  • RAPP N/A
  • Revenue Growth
  • ANGI N/A
  • RAPP N/A
  • 52 Week Low
  • ANGI $11.00
  • RAPP $6.43
  • 52 Week High
  • ANGI $29.20
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 30.74
  • RAPP N/A
  • Support Level
  • ANGI $11.25
  • RAPP N/A
  • Resistance Level
  • ANGI $12.91
  • RAPP N/A
  • Average True Range (ATR)
  • ANGI 0.94
  • RAPP 0.00
  • MACD
  • ANGI -0.14
  • RAPP 0.00
  • Stochastic Oscillator
  • ANGI 12.17
  • RAPP 0.00

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: